Display Options:
Total: 10647
Antibody
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Neoplasms
Macrophage colony stimulating factor receptor inhibitor
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
Small molecule
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma; Leukemia, Myeloid, Acute
Unknown
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Ependymoma; Gliosarcoma; Leukemia, Myeloid, Acute; Medulloblastoma; Breast Neoplasms; Melanoma; Prostatic Neoplasms
Unknown
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic
Unknown
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Parkinson Disease; Carcinoma, Non-Small-Cell Lung; Prostatic Neoplasms, Castration-Resistant
Retinoid X receptor agonist
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; HIV Infections; Acquired Immunodeficiency Syndrome; Hepatitis B, Chronic
Toll-like receptor 7 activator
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Melanoma; Schnitzler Syndrome; Severe Acute Respiratory Syndrome
NACHT, LRR and PYD domains-containing protein 3 inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Pancreatic Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Osteoarthritis, Knee
Delta opioid receptor agonist
Unknown
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Breast Neoplasms; Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Squamous Intraepithelial Lesions
Unknown
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
Unknown
Investigational
Unknown
Unknown
Squamous Cell Carcinoma of Head and Neck
Melanoma-associated antigen 3 vaccine antigen
Small molecule
Investigational
Unknown
Unknown
Asthma; Diabetes Mellitus, Type 2
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
Protein
Investigational
Unknown
Unknown
Glomerulonephritis, IGA
Unknown
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
Enzyme
Investigational
Unknown
Unknown
Heart Failure
Unknown
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
Small molecule
Investigational
Unknown
Unknown
Tuberculosis; Tuberculosis, Pulmonary
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitor
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Lymphoma, Follicular; Lymphoma, T-Cell, Peripheral; Sarcoma, Alveolar Soft Part; Uterine Cervical Neoplasms
Programmed cell death protein 1 inhibitor
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Parkinson Disease
Nociceptin receptor antagonist
Small molecule
Investigational
Unknown
Unknown
Thymoma; Blepharitis
Unknown
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Neoplasms
Unknown
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Dementia; Parkinson Disease
Bcr/Abl fusion protein inhibitor
Small molecule
Investigational
Unknown
Unknown
Unknown
Bradykinin B2 receptor antagonist
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Small Cell Lung Carcinoma
Hepatocyte growth factor receptor inhibitor
Antibody
Investigational
Unknown
Unknown
West Nile Fever
E protein inhibitor
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
Enzyme
Investigational
Unknown
Unknown
Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell
Unknown
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
Unknown
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms; Adenocarcinoma of Lung; Mesothelioma
Elongation factor 2 disrupting agent